Cipla seeks favourable policy for domestic pharma cos, ease of doing biz

Cipla Executive Vice-Chairperson Samina Vaziralli said with the
government returning for a second consecutive five-year term armed
with a strong mandate, expectations are high.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-seeks-favourable-policy-for-domestic-pharma-cos-ease-of-doing-biz/articleshow/70417394.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment